Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 3 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

1
Player Avatar davidr825 (< 20) Submitted: 6/13/2008 7:58:39 PM : Outperform Start Price: $9.54 ACUR Score: -141.47

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical

Member Avatar gablu (< 20) Submitted: 6/22/2011 8:38:17 AM
Recs: 1

8 dollar a share comming soon

Featured Broker Partners


Advertisement